Replies to post #140516 on PharmaCyte Biotech Inc (PMCB)

[Redoocs]

I can put a price on it. 0! It worthless.
Zero! Nothing! Zilch!

SCAM!

[thenewmixer]

how can the FDA will fast track something they rejected

[DragonBear]

Only one will gain the rights to PMCBs-LOL

There is nothing to gain the rights to. The patent has expired.

also because this tech will impact the different ways these companies profit from the current medical landscape Both in Oncology and Diabetes

A chemotherapy concept from 20 yrs ago, isn't going to impact anything. Especially, since it's using a drug already proven to be ineffective for 2nd line pancreatic cancer.

As for diabetes PMCB has nothing other than the empty cellulose CIABs. The wonderful UTS insulin producing cells bombed out over two years ago. Hint: Empty cellulose beads don't produce insulin. Meanwhile competitors in the field are already in CTs, and yrs ahead. Of course the real solution will come in the form of a MHC-1 knockout, insulin producing cell. Not requiring any encapsulation.

Many dont want PMCB to succeed

Then the many already have their wish. A permanently frozen IND on Hold.

FDA will fast track this clinical trial following its approval(2021)

That isn't even close to reality. The current IND will remain on Hold. There will be no CT based on it. Neither does the FDA grant "fast track" without CT data. Usually at the end of Phase 2. What Lohr called Phase 2 back in 1999 is a joke. The FDA doesn't "fast track" jokes.

>$10 a share HUGE

It's HUGE ok, as in huge nonsense. What is this >$25B market cap based on? An IND on Hold? Don't forget, come Jun, Kenny ought to be ready to take the O/S from 2.5B to 3B. Then the dream will be a $30B market cap.

[$Pistol Pete$]

$PMCB when are they going to increase another 2b shares?

https://www.otcmarkets.com/stock/PMCB/security